Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 52 articles:
HTML format



Single Articles


    May 2021
  1. HEIN DM, Ahn C, Aguilera TA, Folkert MR, et al
    Trends and Factors Associated With Receipt of Upfront Surgery for Stage II to III Rectal Adenocarcinoma in the United States, 2006 to 2016.
    Am J Clin Oncol. 2021;44:187-194.
    PubMed     Abstract available


  2. ALABRABA E, Gomez D
    Systematic Review of Treatments for Colorectal Metastases in Elderly Patients to Guide Surveillance Cessation Following Hepatic Resection for Colorectal Liver Metastases.
    Am J Clin Oncol. 2021;44:210-223.
    PubMed     Abstract available


    April 2021
  3. VAN DER KRUIJSSEN DEW, Brouwer NPM, van der Kuil AJS, Verhoeven RHA, et al
    Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer: A Population-Based Study.
    Am J Clin Oncol. 2021 Apr 23. pii: 00000421-900000000-98573.
    PubMed     Abstract available


  4. LI JY, D'Addario J, Tymon-Rosario J, Menderes G, et al
    Benefits of a Multidisciplinary Women's Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy.
    Am J Clin Oncol. 2021;44:143-149.
    PubMed     Abstract available


    January 2021
  5. PUNEKAR SR, Becker DJ
    The Segmentation of Neuroendocrine Neoplasms According to Histology.
    Am J Clin Oncol. 2021;44:43.
    PubMed    


  6. ABDEL-RAHMAN O
    Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
    Am J Clin Oncol. 2021;44:43.
    PubMed    


    December 2020
  7. MARKS EI, Matera R, Olszewski AJ, Yakirevich E, et al
    Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens.
    Am J Clin Oncol. 2020 Dec 8. doi: 10.1097/COC.0000000000000785.
    PubMed     Abstract available


  8. TENG HW
    In Reply: Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2020;43:905-906.
    PubMed    


  9. KOSTEK O
    Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2020;43:905-906.
    PubMed    


  10. SHULMAN K, Musallam S, Epelbaum R, Haim N, et al
    The Older Adults With Rectal Cancer-Does Age Matter?: A Single-center Experience.
    Am J Clin Oncol. 2020;43:861-864.
    PubMed     Abstract available


  11. PUNEKAR SR, Kaakour D, Masri-Lavine L, Hajdu C, et al
    Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
    Am J Clin Oncol. 2020;43:846-849.
    PubMed     Abstract available


    November 2020
  12. GOKSU SY, Ozer M, Kazmi SMA, Aguilera TA, et al
    Racial Disparities in Time to Treatment Initiation and Outcomes for Early Stage Anal Squamous Cell Carcinoma.
    Am J Clin Oncol. 2020;43:762-769.
    PubMed     Abstract available


    October 2020
  13. LEIKER AJ, Wang CJ, Sanford NN, Aguilera TA, et al
    Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal Cancer.
    Am J Clin Oncol. 2020;43:701-708.
    PubMed     Abstract available


  14. SANFORD NN, Dee EC, Ahn C, Kazmi SA, et al
    Recent Trends and Overall Survival of Young Versus Older Adults With Stage II to III Rectal Cancer Treated With and Without Surgery in the United States, 2010-2015.
    Am J Clin Oncol. 2020;43:694-700.
    PubMed     Abstract available


    September 2020
  15. SANFORD NN, Folkert MR, Aguilera TA, Beg MS, et al
    Trends in Primary Surgical Resection and Chemotherapy for Metastatic Colorectal Cancer, 2000-2016.
    Am J Clin Oncol. 2020 Sep 23. doi: 10.1097/COC.0000000000000764.
    PubMed     Abstract available


  16. BOEHMER U, Clark MA, Ozonoff A, Winter M, et al
    Survivors' Perceptions of Quality of Colorectal Cancer Care by Sexual Orientation.
    Am J Clin Oncol. 2020;43:660-666.
    PubMed     Abstract available


    June 2020
  17. BOEHMER U, Clark MA, Ozonoff A, Winter M, et al
    Survivors' Perceptions of Quality of Colorectal Cancer Care by Sexual Orientation.
    Am J Clin Oncol. 2020 Jun 26. doi: 10.1097/COC.0000000000000732.
    PubMed     Abstract available


    May 2020
  18. SANFORD NN, Aguilera TA, Beg MS, Sanjeevaiah A, et al
    Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015.
    Am J Clin Oncol. 2020;43:311-318.
    PubMed     Abstract available


  19. FRAZER ML, Yang G, Felder S, McDonald J, et al
    Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation.
    Am J Clin Oncol. 2020;43:319-324.
    PubMed     Abstract available


    April 2020
  20. SANFORD NN, Ahn C, Beg MS, Sanjeevaiah A, et al
    Stage-specific Conditional Survival Among Young (Age Below 50 y) Versus Older (Age 50 y and Above) Adults With Colorectal Cancer in the United States.
    Am J Clin Oncol. 2020 Apr 21. doi: 10.1097/COC.0000000000000698.
    PubMed     Abstract available


  21. BOSMA NA, Tilley D, Batra A, Cheung WY, et al
    Characterizing Urban-Rural Differences in Colon Cancer Outcomes: A Population-based Analysis Based on Travel Distance to Cancer Center.
    Am J Clin Oncol. 2020 Apr 21. doi: 10.1097/COC.0000000000000703.
    PubMed     Abstract available


    March 2020
  22. JIAO X, Hay JW, Sadeghi S, Barzi A, et al
    Outcomes and Utilization of Adjuvant Chemotherapy for Stage II Colon Cancer in the Oxaliplatin Period: A SEER-Medicare Analysis.
    Am J Clin Oncol. 2020 Mar 16. doi: 10.1097/COC.0000000000000684.
    PubMed     Abstract available


    February 2020
  23. ADDO-TABIRI NO, Chudasama R, Vasudeva R, Leiva O, et al
    Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism.
    Am J Clin Oncol. 2020;43:94-100.
    PubMed     Abstract available


    January 2020
  24. ZHANG C, Yin S, Tan Y, Huang J, et al
    Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer: A Systematic Review and Meta-Analysis.
    Am J Clin Oncol. 2020 Jan 13. doi: 10.1097/COC.0000000000000663.
    PubMed     Abstract available


  25. APPELT AL, Andersen RF, Lindebjerg J, Jakobsen A, et al
    Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial.
    Am J Clin Oncol. 2020;43:9-13.
    PubMed     Abstract available


    December 2019
  26. LEHRER S, Rheinstein PH
    Increased Risk of Acute Myelogenous Leukemia After Early Onset but Not Late-Onset Colorectal Cancer.
    Am J Clin Oncol. 2019 Dec 23. doi: 10.1097/COC.0000000000000658.
    PubMed     Abstract available


  27. MAHAL AR, Johung KL, Mahal BA, Nguyen PL, et al
    An Update to Changing Patterns of Anal Carcinoma in the United States.
    Am J Clin Oncol. 2019;42:887-897.
    PubMed     Abstract available


    November 2019
  28. PRICOLO VE, Steingrimsson J, McDuffie TJ, McHale JM, et al
    Tumor Deposits in Stage III Colon Cancer: Correlation With Other Histopathologic Variables, Prognostic Value, and Risk Stratification-Time to Consider "N2c".
    Am J Clin Oncol. 2019 Nov 19. doi: 10.1097/COC.0000000000000645.
    PubMed     Abstract available


  29. TAI CC, Chen WS, Jiang JK, Yang SH, et al
    Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2019 Nov 5. doi: 10.1097/COC.0000000000000637.
    PubMed     Abstract available


    September 2019
  30. KOUSTAS E, Sarantis P, Theoharis S, Saetta AA, et al
    Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer.
    Am J Clin Oncol. 2019 Sep 11. doi: 10.1097/COC.0000000000000592.
    PubMed     Abstract available


    August 2019
  31. HUO J, Bian J, Xie Z, Hong YR, et al
    Patterns of Postdiagnosis Depression Among Late-Stage Cancer Patients: Do Racial/Ethnic and Sex Disparities Exist?
    Am J Clin Oncol. 2019;42:675-681.
    PubMed     Abstract available


    July 2019
  32. PEABODY J, Rahim A, Wilcox B, McGehee C, et al
    Clinical Utility of a Blood-based Protein Assay on Diagnostic Colonoscopy Referrals for Elevated-risk Colorectal Cancer Patients in Primary Care.
    Am J Clin Oncol. 2019 Jul 19. doi: 10.1097/COC.0000000000000578.
    PubMed     Abstract available


    June 2019
  33. KOENIG JL, Toesca DAS, Harris JP, Tsai CJ, et al
    Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.
    Am J Clin Oncol. 2019 Jun 3. doi: 10.1097/COC.0000000000000554.
    PubMed     Abstract available


  34. WEGNER RE, Abel S, Hasan S, White RJ, et al
    Trends in Radiation Dose and Technique For Anal Canal Squamous Cell Carcinoma.
    Am J Clin Oncol. 2019;42:519-526.
    PubMed     Abstract available


    April 2019
  35. ALI ND, Donohue K, Zandieh S, Chen C, et al
    Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living >/=24 Months: A Single Institutional Study.
    Am J Clin Oncol. 2019 Apr 9. doi: 10.1097/COC.0000000000000535.
    PubMed     Abstract available


    March 2019
  36. LLOYD S, Baraghoshi D, Tao R, Garrido-Laguna I, et al
    Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival.
    Am J Clin Oncol. 2019 Mar 5. doi: 10.1097/COC.0000000000000529.
    PubMed     Abstract available


    February 2019
  37. AHMED S, Baig T, Iqbal N, Le D, et al
    Effects of Social and Contextual Factors Including Marital Status and Children on the Use of Palliative Chemotherapy in Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2019 Feb 15. doi: 10.1097/COC.0000000000000530.
    PubMed     Abstract available


    July 2018
  38. CUBILLO A, Alvarez-Gallego R, Munoz M, Pond G, et al
    Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2018 Jul 2. doi: 10.1097/COC.0000000000000474.
    PubMed     Abstract available


    May 2018
  39. CHEN EY, Blanke CD, Haller DG, Benson AB, et al
    A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000465.
    PubMed     Abstract available


    April 2018
  40. BATES JE, Choi G, Usuki KY, Katz AW, et al
    Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy.
    Am J Clin Oncol. 2018 Apr 16. doi: 10.1097/COC.0000000000000445.
    PubMed     Abstract available


    March 2018
  41. MCCLURE LA, Sussman DA, Hernandez MN, Tannenbaum SL, et al
    Factors Associated With Receipt of Radiation Therapy for Rectal Cancer.
    Am J Clin Oncol. 2018;41:227-229.
    PubMed     Abstract available


    February 2018
  42. NGUYEN P, Wuthrick E, Chablani P, Robinson A, et al
    Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
    Am J Clin Oncol. 2018;41:140-146.
    PubMed     Abstract available


  43. DESHMUKH AA, Zhao H, Franzini L, Lairson DR, et al
    Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States.
    Am J Clin Oncol. 2018;41:121-127.
    PubMed     Abstract available


    January 2018
  44. LAURENT M, Des Guetz G, Bastuji-Garin S, Culine S, et al
    Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.
    Am J Clin Oncol. 2018;41:73-80.
    PubMed     Abstract available


  45. SHANKARAN V, Ortendahl JD, Purdum AG, Bolinder B, et al
    Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States.
    Am J Clin Oncol. 2018;41:65-72.
    PubMed     Abstract available


  46. QIU H, Katz AW, Chowdhry AK, Usuki KY, et al
    Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
    Am J Clin Oncol. 2018;41:53-58.
    PubMed     Abstract available


    December 2017
  47. CHABLANI P, Nguyen P, Pan X, Robinson A, et al
    Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery.
    Am J Clin Oncol. 2017;40:561-568.
    PubMed     Abstract available


  48. VOONG KR, Rashid A, Crane CH, Minsky BD, et al
    Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
    Am J Clin Oncol. 2017;40:555-560.
    PubMed     Abstract available


  49. OSTI MF, Nicosia L, Agolli L, Gentile G, et al
    Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy.
    Am J Clin Oncol. 2017;40:535-542.
    PubMed     Abstract available


  50. AHN DH, Wu C, Wei L, Williams TM, et al
    The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
    Am J Clin Oncol. 2017;40:531-534.
    PubMed     Abstract available


    October 2017
  51. YEOP OH S, Bae Kim Y, Wook Suh K
    Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer.
    Am J Clin Oncol. 2017;40:512-516.
    PubMed     Abstract available


  52. CHARLTON ME, Karlitz JJ, Schlichting JA, Chen VW, et al
    Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.
    Am J Clin Oncol. 2017;40:498-506.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: